Eli Lil­ly sues HHS to halt any 340B-re­lat­ed mon­e­tary penal­ties

The Biden ad­min­is­tra­tion’s fight with drug­mak­ers over a drug dis­count pro­gram, known as 340B, is start­ing to boil over.

Just days af­ter HHS set a June 1 dead­line for bio­phar­ma com­pa­nies to get in line with the de­part­ment’s views on the 340B statute and al­low hos­pi­tals’ con­tract phar­ma­cies to gain ac­cess to deeply dis­count­ed drugs or pay steep fines, Eli Lil­ly late Thurs­day filed a mo­tion in an In­di­ana dis­trict court to stop HHS in its tracks.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER